Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtrer
Plus de filtres











Gamme d'année
1.
Electron. j. biotechnol ; Electron. j. biotechnol;48: 53-61, nov. 2020. ilus, graf
Article de Anglais | LILACS | ID: biblio-1254710

RÉSUMÉ

BACKGROUND: Alzheimer's disease (AD) is a chronic, progressive neurodegenerative disease. Recent studies have reported the close association between cognitive function in AD and purinergic receptors in the central nervous system. In the current study, we investigated the effect of CD73 inhibitor α, ß-methylene ADP (APCP) on cognitive impairment of AD in mice, and to explore the potential underlying mechanisms. RESULTS: We found that acute administration of Aß1­42 (i.c.v.) resulted in a significant increase in adenosine release by using microdialysis study. Chronic administration of APCP (10, 30 mg/kg) for 20 d obviously mitigated the spatial working memory impairment of Aß1­42-treated mice in both Morris water maze (MWM) test and Y-maze test. In addition, the extracellular adenosine production in the hippocampus was inhibited by APCP in Aß-treated mice. Further analyses indicated expression of acetyltransferase (ChAT) in hippocampus of mice of was significantly reduced, while acetylcholinesterase (AChE) expression increased, which compared to model group. We observed that APCP did not significantly alter the NLRP3 inflammasome activity in hippocampus, indicating that anti-central inflammation seems not to be involved in APCP effect. CONCLUSIONS: In conclusion, we report for the first time that inhibition of CD73 by APCP was able to protect against memory loss induced by Aß1­42 in mice, which may be due to the decrease of CD73-driven adenosine production in hippocampus. Enhancement of central cholinergic function of the central nervous system may also be involved in the effects of APCP.


Sujet(s)
Animaux , Mâle , Souris , ADP/analogues et dérivés , Maladies neurodégénératives/prévention et contrôle , Hippocampe , Nucleotidases/antagonistes et inhibiteurs , Acetylcholinesterase , ADP/administration et posologie , Maladie d'Alzheimer/prévention et contrôle , Test du labyrinthe aquatique de Morris , Souris de lignée C57BL
2.
Exp Parasitol ; 169: 111-8, 2016 Oct.
Article de Anglais | MEDLINE | ID: mdl-27531705

RÉSUMÉ

The protozoan parasite Leishmania amazonensis is the etiological agent of cutaneous leishmaniasis. During its life cycle, the flagellated metacyclic promastigote forms are transmitted to vertebrate hosts by sandfly bites, and they develop into amastigotes inside macrophages, where they multiply. L. amazonensis possesses a bifunctional enzyme, called 3'-nucleotidase/nuclease (3'NT/NU), which is able to hydrolyze extracellular 3'-monophosphorylated nucleosides and nucleic acids. 3'NT/NU plays an important role in the generation of extracellular adenosine and has been described as a key enzyme in the acquisition of purines by trypanosomatids. Furthermore, it has been observed that 3'NT/NU also plays a valuable role in the establishment of parasitic infection. In this context, this study aimed to investigate the modulation of the 3'-nucleotidase (3'NT) activity of L. amazonensis by several nucleotides. It was observed that 3'NT activity is inhibited by micromolar concentrations of guanosine and guanine nucleotides. The inhibition promoted by 5'-GMP on the 3'NT activity of L. amazonensis is reversible and uncompetitive because the addition of the inhibitor decreased the kinetic parameters Km and Vmax. Finally, we found that the addition of 5'-GMP is able to reverse the stimulation promoted by 3'-AMP in a macrophage-parasite interaction assay. The determination of compounds that can inhibit the 3'NT activity of Leishmania is very important because this enzyme does not occur in mammals, making it a potential therapeutic target.


Sujet(s)
Guanosine diphosphate/pharmacologie , Guanosine monophosphate/pharmacologie , Guanosine triphosphate/pharmacologie , Leishmania mexicana/enzymologie , Nucleotidases/antagonistes et inhibiteurs , Animaux , Cinétique , Leishmania mexicana/effets des médicaments et des substances chimiques , Macrophages/parasitologie , Souris , Nucleotidases/métabolisme , Cellules RAW 264.7
3.
CNS Neurol Disord Drug Targets ; 11(6): 739-50, 2012 Sep.
Article de Anglais | MEDLINE | ID: mdl-22963442

RÉSUMÉ

Extracellular nucleotide and nucleoside are signaling molecules with a wide range of actions in the central nervous system (CNS). Extracellular ATP is released by several mechanisms involving ATP binding cassette transporters, hemichannels, P2X7 receptors, or volume-sensitive chloride channels. The levels of ATP and its hydrolysis product, adenosine, in the synaptic cleft are controlled by a complex cascade of cell surface-located enzymes collectively known as ectonucleotidases. There are four major families of ectonucleotidases: ecto-nucleoside triphosphate diphosphohydrolases (E-NTPDases), ecto-nucleotide pyrophosphatase/phosphodiesterases (E-NPPs), alkaline phosphatases, and ecto-5'- nucleotidase. Besides the production of adenosine through nucleotide hydrolysis, this neuromodulator can be released as adenosine per se by equilibrative and/or concentrative nucleoside transporters. In this review, the involvement of nucleotide/nucleoside transporters and ectonucleotidases in the pathophysiology of brain disorders is discussed. The identification of compounds able to modulate the activity of these players in purinergic neurotransmission and their implications in neurological disorders as potential targets for drug discovery is also highlighted.


Sujet(s)
Adénosine triphosphate/métabolisme , Encéphalopathies/métabolisme , Transporteurs de nucléosides/métabolisme , Nucleotidases/métabolisme , Transporteurs de nucléotides/métabolisme , 5'-Nucleotidase/métabolisme , Phosphatase alcaline/métabolisme , Animaux , Encéphalopathies/traitement médicamenteux , Humains , Thérapie moléculaire ciblée , Nucleoside-triphosphatase/métabolisme , Nucleotidases/antagonistes et inhibiteurs , Phosphodiesterases/métabolisme , Pyrophosphatases/métabolisme , Transduction du signal
4.
Exp Parasitol ; 131(1): 63-8, 2012 May.
Article de Anglais | MEDLINE | ID: mdl-22449511

RÉSUMÉ

Free Cu(2+) is toxic due to the capacity of free copper ions to catalyze the production of reactive oxygen species (ROS) that can modify the structure and/or function of biomolecules. In addition, non-specific binding to enzymes, which modifies their catalytic activities, can occur. In this work, the mechanisms underlying the ability of copper to inhibit 3'-nucleotidase from Leishmania amazonensis (La3'-nucleotidase) were investigated. To that end, La3'-nucleotidase activity was assayed with CuCl(2) in the presence of ascorbate or hydrogen peroxide to discriminate non-specific binding effects from pro-oxidant effects of copper. Copper inhibitory effects were greater at more acidic pH than at alkaline pH. The addition of enzyme substrate, adenosine 3'-monophosphate (3'AMP), prevented the inhibition of enzyme activity by copper. Thiol-containing compounds were able to protect the enzyme activity against inhibition due to copper. The specific copper chelating agent bathocuproine sulphonate (BCS) restored enzyme activity after pre-treatment of the enzyme with copper. La3'-nucleotidase activity was found to be resistant to ROS generated during oxidation reactions of ascorbate and hydrogen peroxide catalyzed by copper. Our results suggest that Cu(2+) ions exert their inhibitory effects by binding to specific motifs of the 3'-nucleotidase protein and that the enzyme appears to be extremely resistant to ROS.


Sujet(s)
Cuivre/pharmacologie , Leishmania mexicana/enzymologie , Nucleotidases/antagonistes et inhibiteurs , Animaux , Acide ascorbique/métabolisme , Cuivre/métabolisme , Cricetinae , Cystéine/pharmacologie , Dithiothréitol/pharmacologie , Relation dose-effet des médicaments , Glutathion/pharmacologie , Humains , Peroxyde d'hydrogène/métabolisme , Concentration en ions d'hydrogène , Leishmania mexicana/effets des médicaments et des substances chimiques , 2-Sulfanyl-éthanol/pharmacologie , Nucleotidases/métabolisme , Oxydoréduction , Oxygène/métabolisme , Phénanthrolines/pharmacologie , Espèces réactives de l'oxygène/métabolisme
5.
Cell Biochem Funct ; 29(8): 703-7, 2011 Dec.
Article de Anglais | MEDLINE | ID: mdl-21932293

RÉSUMÉ

With the evidence that curcumin may be a potent neuroprotective agent and that cigarette smoke is associated with a decline in the cognitive performance as our bases, we investigated the activities of Ecto-Nucleoside Triphosphate Diphosphohydrolase (NTPDase), 5'-nucleotidase and acetylcholinesterase (AChE) in cerebral cortex synaptosomes from cigarette smoke-exposed rats treated with curcumin (Cur). The experimental procedures entailed two sets of experiments. In the first set, the groups were vehicle, Cur 12·5, 25 and 50 mg·kg(-1) ; those in the second set were vehicle, smoke, smoke and Cur 12·5, 25 and 50 mg·kg(-1) . Curcumin prevented the increased NTPDase, 5'-nucleotidase and AChE activities caused by smoke exposure. We suggest that treatment with Cur was protective because the decrease of ATP and acetylcholine (ACh) concentrations is responsible for cognitive impairment, and both ATP and ACh have key roles in neurotransmission.


Sujet(s)
Acetylcholinesterase/métabolisme , Adenosine triphosphatases/métabolisme , Cortex cérébral/enzymologie , Curcumine/administration et posologie , Exposition environnementale/effets indésirables , Nicotiana/effets indésirables , Fumée/effets indésirables , Synaptosomes/enzymologie , Adenosine triphosphatases/antagonistes et inhibiteurs , Animaux , Cortex cérébral/effets des médicaments et des substances chimiques , Antienzymes/administration et posologie , Humains , Mâle , Nucleotidases/antagonistes et inhibiteurs , Nucleotidases/métabolisme , Rats , Rat Wistar , Synaptosomes/effets des médicaments et des substances chimiques , Pollution par la fumée de tabac/effets indésirables
6.
Parasitol Res ; 105(6): 1701-6, 2009 Nov.
Article de Anglais | MEDLINE | ID: mdl-19756747

RÉSUMÉ

Trichomonas vaginalis infection may be influenced by the vaginal concentrations of estrogens. We have investigated the effects of 17beta-estradiol and dehydroepiandrosterone sulfate (DHEAS) on the ecto-5'-nucleotidase activity in fresh clinical (VP60) and in long-term-grown (30236 ATCC) isolates of T. vaginalis. In vitro exposure to DHEAS and 17beta-estradiol did not induce any changes in adenosine monophosphate (AMP) hydrolysis in these isolates. The treatment of parasites in the presence of DHEAS (0.01-1.0 microM) for 2 h inhibited AMP hydrolysis in VP60 isolate, whereas there were no significant changes in nucleotide hydrolysis in the presence of 17beta-estradiol. DHEAS and 17beta-estradiol (0.01-1.0 microM) for 2 h inhibited AMP hydrolysis in 30236 isolate. The 12 treatment with 0.1 microM DHEAS inhibited AMP hydrolysis, whereas 17beta-estradiol did not alter the nucleotide hydrolysis in VP60 isolate. Our findings have shown that the complex effect of steroid hormones and their receptors on T. vaginalis may promote changes in ecto-5'-nucleotidase activity during exposure to these hormones.


Sujet(s)
AMP/métabolisme , Hormones/métabolisme , Nucleotidases/antagonistes et inhibiteurs , Stéroïdes/métabolisme , Trichomonas vaginalis/effets des médicaments et des substances chimiques , Trophozoïtes/effets des médicaments et des substances chimiques , Trophozoïtes/métabolisme , Animaux , Sulfate de déhydroépiandrostérone/métabolisme , Oestradiol/métabolisme , Hydrolyse , Trichomonas vaginalis/métabolisme
7.
Life Sci ; 80(19): 1784-91, 2007 Apr 17.
Article de Anglais | MEDLINE | ID: mdl-17363004

RÉSUMÉ

ATP exerts a proinflammatory role and induces cytokine release by acting at P2X(7) receptors. The product of ATP hydrolysis is the nucleoside adenosine, an important immunomodulator. The main source of extracellular adenosine is the hydrolysis of extracellular ATP by a group of ecto-enzymes: ENTPDase family, NPP family and ecto-5'-nucleotidase. Considering the role of ATP and adenosine in inflammatory processes, we investigated the effect of lipopolysaccharide on ectonucleotidases activities and expression in lymphocytes from mesenteric lymph nodes and serum of rats, in order to better understand the involvement of extracellular nucleotide hydrolysis in an endotoxemia model. We observed significant changes on nucleotidase activities from lymphocytes and serum of rats after in vitro and in vivo exposure to LPS. In vitro results have shown an increase on nucleotide hydrolysis in lymphocytes and a decrease on the enzyme activity of NPP in blood serum. In vivo, we observed an increase on nucleotide hydrolysis in lymphocytes and a decrease in the hydrolysis of all nucleotides tested in blood serum. After 24 and 48 h of LPS treatment, there was a reduction in NTPDase1, 2, 3 and ecto-5'-nucleotidase transcripts. These results suggest that there is a time-dependent enhancement of extracellular nucleotides metabolism in lymphocytes and blood serum after the induction of an endotoxemic model. The changes observed suggest that these enzymes can act in the regulation of extracellular nucleosides and nucleotides in a model able to trigger inflammatory process.


Sujet(s)
Apyrase/antagonistes et inhibiteurs , Endotoxémie/enzymologie , Lymphocytes/enzymologie , Nucleotidases/antagonistes et inhibiteurs , Nucléotides adényliques/sang , Nucléotides adényliques/métabolisme , Animaux , Apyrase/sang , Apyrase/génétique , Modèles animaux de maladie humaine , Escherichia coli/immunologie , Expression des gènes/effets des médicaments et des substances chimiques , Hydrolyse , Lipopolysaccharides/pharmacologie , Lymphocytes/effets des médicaments et des substances chimiques , Mâle , Nucleotidases/sang , Nucleotidases/génétique , Rats , Rat Wistar
8.
Arch Insect Biochem Physiol ; 61(1): 1-9, 2006 Jan.
Article de Anglais | MEDLINE | ID: mdl-16380977

RÉSUMÉ

In this study, we describe the ability of intact fat body of an insect, Rhodnius prolixus, to hydrolyze extracellular ATP. In these fat bodies, the ATP hydrolysis was low in the absence of any divalent metal, and was stimulated by MgCl(2). Both activities (in the absence or presence of MgCl(2)) were linear with time for at least 30 min. In order to confirm the observed nucleotidase activities as ecto-nucleotidases, we used an impermeant inhibitor, DIDS (4, 4'-diisothiocyanostylbene 2'-2'-disulfonic acid). This reagent inhibited both nucleotidase activities and its inhibitory effect was suppressed by ATP. Both ecto-nucleotidase activities were insensitive to inhibitors of other ATPase and phosphatase activities, such as oligomycin, sodium azide, bafilomycin, ouabain, vanadate, molybdate, sodium fluoride, levamizole, tartrate, p-NPP, sodium phosphate, and suramin. Concanavalin A, activator of some ecto-ATPases, was able to stimulate the Mg(2+)-independent nucleotidase activity, but not the Mg(2+)-dependent one. The Mg(2+)-independent nucleotidase activity was enhanced with increases in the pH in the range between 6.4-8.0, but the Mg(2+)-dependent nucleotidase activity was not affected. Besides MgCl(2) , the ecto-ATPase activity was also stimulated by CaCl(2),() MnCl(2), and SrCl(2), but not by ZnCl(2). ATP, ADP, and AMP were the best substrates for the Mg(2+)-dependent ecto-nucleotidase activity, and CTP, GTP, and UTP produced very low reaction rates. However, the Mg(2+)-independent nucleotidase activity recognized all these nucleotides producing similar reaction rates, but GTP was a less efficient substrate. The possible role of the two ecto-nucleotidase activities present on the cell surface of fat body of Rhodnius prolixus, which are distinguished by their substrate specificity and their response to Mg(2+), is discussed.


Sujet(s)
Corps gras/enzymologie , Nucleotidases/métabolisme , Rhodnius/enzymologie , Acide 4,4'-diisothiocyano-stilbène-2,2'-disulfonique/pharmacologie , Adenosine triphosphatases/effets des médicaments et des substances chimiques , Adenosine triphosphatases/métabolisme , Adénosine triphosphate/métabolisme , Animaux , Corps gras/métabolisme , Femelle , Concentration en ions d'hydrogène , Hydrolyse , Chlorure de magnésium/pharmacologie , Nucleotidases/antagonistes et inhibiteurs , Nucleotidases/composition chimique , Nucléotides/métabolisme , Rhodnius/métabolisme , Spécificité du substrat
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE